AI-Based Mobile Intervention on Medication Non-Adherence and Transition
Recruiting · NCT07445074 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Central Florida
View the official record on ClinicalTrials.gov →Interventions studied
Medilepsy® Chatbot AI-EnhancedMedilepsy® Chatbot Standard
What this trial is about
This study aims to examine whether the AI-personalized version of the Medilepsy® app is more effective than the non-AI (standard version without AI personalization) can improve key outcomes, such as medical adherence and transition readiness, among underserved adolescents and young adults with epilepsy, ages 14-24, in Florida, USA. Outcomes are organized into primary (effectiveness), secondary (usability), and exploratory (language experience) endpoints.
Who can take part
Age range
14 Years to 24 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Diagnosed with epilepsy
- Currently prescribed anti-seizure medicine (ASMs)
- Identified as part of an underserved population, defined as meeting at least one of the following: member of a racial or ethnic group historically underrepresented in research or healthcare or low-income status (e.g., eligible for public assistance or government-subsidized health coverage)
- Are between 14-17 years old and able to provide assent, with a parent or LAR present to receive app notifications throughout the study
- Are between 18-24 years old and able to provide informed consent
- Able to read, speak, and write in English
- Resides in Florida
- Receive outpatient medical services
Exclusion criteria
- They do not own a mobile device with internet access.
- They have a history of severe intellectual disability.
- They are unable to operate a mobile device (keyboard or touchscreen).
- Reside in an in-patient setting.
- Adults unable to consent.
- Pregnant women (excluded because pregnancy is not relevant to the study focus).
- Prisoners.
Where it is running
2 locations listed across 1 US state.
- Orlando Health Arnold Palmer Hospital - Orlando, Florida, United States
- Orlando Health Orlando Regional Medical Center - Orlando, Florida, United States